280 related articles for article (PubMed ID: 29517697)
21. 18F-FDG PET/CT in gastric MALT lymphoma: a bicentric experience.
Albano D; Bertoli M; Ferro P; Fallanca F; Gianolli L; Picchio M; Giubbini R; Bertagna F
Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):589-597. PubMed ID: 27619357
[TBL] [Abstract][Full Text] [Related]
22. 18F-FDG Versus 68Ga-FAPI PET/CT in Visualizing Primary Hepatic Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue.
Pang Y; Zhao L; Shang Q; Meng T; Chen H
Clin Nucl Med; 2022 Apr; 47(4):375-377. PubMed ID: 34661557
[TBL] [Abstract][Full Text] [Related]
23. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
24. Comparison between endoscopic macroscopic classification and F-18 FDG PET findings in gastric mucosa-associated lymphoid tissue lymphoma patients.
Hirose Y; Kaida H; Ishibashi M; Uozumi J; Arikawa S; Kurata S; Hayabuchi N; Nakahara K; Ohshima K
Clin Nucl Med; 2012 Feb; 37(2):152-7. PubMed ID: 22228338
[TBL] [Abstract][Full Text] [Related]
25. Positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose (F18-FDG) does not visualize extranodal B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT)-type.
Hoffmann M; Kletter K; Diemling M; Becherer A; Pfeffel F; Petkov V; Chott A; Raderer M
Ann Oncol; 1999 Oct; 10(10):1185-9. PubMed ID: 10586335
[TBL] [Abstract][Full Text] [Related]
26. Pulmonary mucosa-associated lymphoid tissue type lymphoma with increased accumulation of fluorine 18-fluorodeoxyglucose on positron emission tomography.
Natsag J; Tomiyama N; Inoue A; Bryce TJ; Damdinsuren B; Honda O; Mihara N; Sumikawa H; Fujita S; Johkoh T; Hatazawa J; Nakamura H
J Comput Assist Tomogr; 2005; 29(5):640-3. PubMed ID: 16163034
[TBL] [Abstract][Full Text] [Related]
27. 18F-FDG PET/CT Findings of MALT Lymphoma of Ureter.
He L; Deng Y; Deng Y; Xie H; Zhang W
Clin Nucl Med; 2022 Sep; 47(9):828-829. PubMed ID: 35930711
[TBL] [Abstract][Full Text] [Related]
28. F-18 FDG PET/CT evaluation of radiotherapy response in rare case of mucosa-associated lymphoid tissue lymphoma.
Minamimoto R; Tateishi U; Tomita N; Inayama Y; Omura-Minamisawa M; Tayama Y; Hata M; Kubota Y; Inoue T
Ann Nucl Med; 2010 Feb; 24(2):115-9. PubMed ID: 20077163
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of SUVmax measured by pretreatment 18F-FDG PET/CT in patients with primary gastric lymphoma.
Hwang JP; Lim I; Byun BH; Kim BI; Choi CW; Lim SM
Nucl Med Commun; 2016 Dec; 37(12):1267-1272. PubMed ID: 27482643
[TBL] [Abstract][Full Text] [Related]
30. 18F-Fluorodeoxyglucose (FDG)-positron emission tomography/computed tomography in mucosa-associated lymphoid tissue lymphoma: variation in 18F-FDG avidity according to site involvement.
Park SH; Lee JJ; Kim HO; Lee DY; Suh C; Jung HY; Choi KD; Kim DH; Huh J; Ryu JS
Leuk Lymphoma; 2015; 56(12):3288-94. PubMed ID: 25804932
[TBL] [Abstract][Full Text] [Related]
31. 18F-Fluoro-deoxy-glucose positron emission tomography in lymphoma of mucosa-associated lymphoid tissue: histology makes the difference.
Hoffmann M; Wöhrer S; Becherer A; Chott A; Streubel B; Kletter K; Raderer M
Ann Oncol; 2006 Dec; 17(12):1761-5. PubMed ID: 16980600
[TBL] [Abstract][Full Text] [Related]
32. 18F-fluorodeoxyglucose positron emission tomography/computed tomography findings in mucosa-associated lymphoid tissue lymphoma of the larynx: a case report and literature review.
Zhao K; Luo YZ; Zhou SH; Dai BL; Luo XM; Yan SX; Wang QY; Ling L
J Int Med Res; 2012; 40(3):1192-206. PubMed ID: 22906294
[TBL] [Abstract][Full Text] [Related]
33. 18F-FDG PET/CT in splenic marginal zone lymphoma.
Albano D; Giubbini R; Bertagna F
Abdom Radiol (NY); 2018 Oct; 43(10):2721-2727. PubMed ID: 29500652
[TBL] [Abstract][Full Text] [Related]
34. Pre-Therapeutic Total Lesion Glycolysis on [
Mayerhoefer ME; Staudenherz A; Kiesewetter B; Weber M; Simonitsch-Klupp I; Gibbs P; Dolak W; Lukas J; Raderer M
Mol Imaging Biol; 2019 Dec; 21(6):1192-1199. PubMed ID: 30847823
[TBL] [Abstract][Full Text] [Related]
35. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
[TBL] [Abstract][Full Text] [Related]
36. 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) for staging and follow-up of marginal zone B-cell lymphoma.
Hoffmann M; Kletter K; Becherer A; Jäger U; Chott A; Raderer M
Oncology; 2003; 64(4):336-40. PubMed ID: 12759529
[TBL] [Abstract][Full Text] [Related]
37. Mucosa-associated lymphoid tissue lymphoma with unusual
Zhang NS; Shi F; Kong L; Zhu H
World J Gastroenterol; 2017 Jan; 23(3):551-559. PubMed ID: 28210093
[TBL] [Abstract][Full Text] [Related]
38. Whole-body positron emission tomography/computed tomography imaging and staging of orbital lymphoma.
Roe RH; Finger PT; Kurli M; Tena LB; Iacob CE
Ophthalmology; 2006 Oct; 113(10):1854-8. PubMed ID: 16860867
[TBL] [Abstract][Full Text] [Related]
39. Dural MALT Lymphoma Detected by 11C-Methionine PET/CT.
Annunziata S; Cuccaro A; Caldarella C; Hohaus S
Clin Nucl Med; 2017 Dec; 42(12):962-963. PubMed ID: 28902730
[TBL] [Abstract][Full Text] [Related]
40. F-18-FDG-PET in a patient with Hashimoto's thyroiditis and MALT lymphoma recurrence of the thyroid.
Mikosch P; Würtz FG; Gallowitsch HJ; Kresnik E; Lind P
Wien Med Wochenschr; 2003; 153(3-4):89-92. PubMed ID: 12658970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
